Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
GBT holding history
Global Blood Therapeutics, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GBT overviewAll 13F holders of GBTFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −1,175,879−100.0% | Sold out | Holders |
| Q3 2022 | 1,175,879 | $80.1M | 11.3% | −269,687−18.7% | Reduced | Holders |
| Q2 2022 | 1,445,566 | $46.2M | 9.2% | +478,739+49.5% | Added | Holders |
| Q1 2022 | 966,827 | $33.5M | 8.9% | +186,347+23.9% | Added | Holders |
| Q4 2021 | 780,480 | $22.8M | 6.5% | – | No prior filing | Holders |